ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q3 2017. The put-call ratio across all filers is 4.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $516,000 | +64.3% | 4,110 | -30.5% | 0.03% | +78.9% |
| Q4 2019 | $314,000 | -87.5% | 5,914 | -90.8% | 0.02% | -77.6% |
| Q1 2018 | $2,509,000 | -8.2% | 64,166 | -0.3% | 0.08% | +7.6% |
| Q4 2017 | $2,732,000 | +13.9% | 64,368 | +0.1% | 0.08% | 0.0% |
| Q3 2017 | $2,399,000 | +22.8% | 64,281 | 0.0% | 0.08% | 0.0% |
| Q2 2017 | $1,953,000 | +13.9% | 64,281 | -0.8% | 0.08% | -12.2% |
| Q1 2017 | $1,715,000 | +43.9% | 64,781 | +38.7% | 0.09% | +15.4% |
| Q4 2016 | $1,192,000 | -36.8% | 46,701 | -10.4% | 0.08% | -29.1% |
| Q3 2016 | $1,886,000 | +6.6% | 52,101 | 0.0% | 0.11% | -21.4% |
| Q2 2016 | $1,770,000 | +14.7% | 52,101 | -10.9% | 0.14% | +44.3% |
| Q1 2016 | $1,543,000 | +25.2% | 58,465 | +131.4% | 0.10% | -42.6% |
| Q4 2015 | $1,232,000 | -27.1% | 25,270 | -49.2% | 0.17% | +275.6% |
| Q2 2014 | $1,690,000 | +200.7% | 49,761 | +205.3% | 0.04% | +221.4% |
| Q1 2014 | $562,000 | – | 16,299 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |